CWF19L2: Regulating The Cell Cycle and Potential Drug Target (G143884)

Target Name: CWF19L2

NCBI ID: G143884

CWF19L2

Other Name(s): CWF19 like cell cycle control factor 2 | CWF19-like protein 2 | C19L2_HUMAN | CWF19 like 2, cell cycle control

CWF19L2: Regulating The Cell Cycle and Potential Drug Target

CWF19L2, also known as CWF19 like cell cycle control factor 2, is a protein that plays a crucial role in regulating the cell cycle. The cell cycle is the process by which a cell grows, replicates its DNA, and divides. regulated by a complex network of proteins, including CWF19L2.

CWF19L2 is a 21-kDa protein that is expressed in most tissues of the body. It is a key regulator of the G1 phase of the cell cycle, which is the phase of growth and preparation for cell division. During the G1 phase, CWF19L2 helps to ensure that the cell grows and prepares for cell division by regulating the levels of different cell cycle proteins.

One of the key functions of CWF19L2 is its ability to inhibit the activity of the cyclin D1 protein. Cyclin D1 is a key regulator of the G1 phase of the cell cycle and is involved in the progression of the cell cycle. When the cell cycle reaches the G1 phase, the levels of cyclin D1 increase, and this increase in activity triggers the G1 checkpoint, a critical step in the cell cycle that ensures that the cell has enough active genetic material for cell division.

CWF19L2 helps to regulate the levels of cyclin D1 by inhibiting its activity. This inhibition allows the cell to enter the G2 phase of the cell cycle, where the cell prepares for cell division by producing more organelles and increasing its size. In the G2 phase, the levels of CWF19L2 increase, and this increase in activity helps to ensure that the cell enters the M1 phase of the cell cycle, where the cell divides.

Another function of CWF19L2 is its ability to regulate the levels of the protein p21. P21 is a key regulator of the cell cycle and is involved in the regulation of cell growth and differentiation. During the G1 phase, the levels of p21 increase, and this increase in activity triggers the G1 checkpoint, a critical step in the cell cycle that ensures that the cell has enough active genetic material for cell division.

CWF19L2 helps to regulate the levels of p21 by inhibiting its activity. This inhibition allows the cell to enter the G2 phase of the cell cycle, where the cell prepares for cell division by producing more organelles and increasing its size. In the G2 phase, the levels of CWF19L2 increase, and this increase in activity helps to ensure that the cell enters the M1 phase of the cell cycle, where the cell divides.

CWF19L2 is also involved in the regulation of the cycle protein p200, which is a key regulator of the cell cycle. p200 helps to ensure that the cell cycle proceeds in a timely and orderly manner and is involved in the regulation of cell growth and differentiation.

CWF19L2 is a drug target that has the potential to be a new treatment for various diseases. One of the main targets of CWF19L2 is the regulation of the cell cycle, and drugs that inhibit the activity of CWF19L2 have been shown to be effective in treating various diseases. diseases. For example, inhibitors of CWF19L2 have been shown to be effective in treating cancer, including breast, ovarian, and prostate cancers.

In addition to its role in regulating the cell cycle, CWF19L2 is also involved in the regulation of various other cellular processes, including cell adhesion, migration, and invasion. This suggests that CWF19L2 may have other potential functions as well, and further research is needed to fully understand its role in these processes.

Overall, CWF19L2 is a protein that plays a crucial role in regulating the cell cycle. Its ability to inhibit the activity of cyclin D1 and p21, as well as its involvement in the regulation of p20

Protein Name: CWF19 Like Cell Cycle Control Factor 2

The "CWF19L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CWF19L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets